The plasma you donate is used to produce therapies that help treat a great variety of rare diseases.
Take, for example, Alpha 1-Antitrypsin deficiency, a rare, genetic disease characterized by the lack of the protein Alpha-1-Antitrypsin (AAT) – a protein vital to the functioning of our lungs.
In the US alone, 80,000 to 100,000 people suffer from AAT deficiency. And since it takes 900 plasma donations to treat one patient for one year, their hope for a much happier and healthier life lies with donors who do not just donate plasma but donate it regularly. (Let’s not forget that these are the figures for just one of the several rare diseases that plasma therapies help treat.)
This demands commitment.
And it is for this commitment that plasma companies compensate their donors – for the time and effort they expend to donate plasma.
Indeed, the primary challenge patients face today is a shortage of plasma therapies. Their demand today outweighs their supply, which comes down to a scarcity of plasma donors. Though different collection centers offer different amounts, recognizing the contribution of donors could encourage them to donate more, thereby ensuring an adequate supply of plasma.
Want to donate plasma? Find more information here.